Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spruce Biosciences (SPRB) Depreciation & Amortization (CF) (2022 - 2025)

Spruce Biosciences (SPRB) has disclosed Depreciation & Amortization (CF) for 4 consecutive years, with $5000.0 as the latest value for Q4 2025.

  • Quarterly Depreciation & Amortization (CF) fell 44.44% to $5000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $21000.0 through Dec 2025, down 54.35% year-over-year, with the annual reading at $21000.0 for FY2025, 54.35% down from the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 was $5000.0 at Spruce Biosciences, up from $3000.0 in the prior quarter.
  • The five-year high for Depreciation & Amortization (CF) was $24000.0 in Q4 2022, with the low at $3000.0 in Q3 2025.
  • Average Depreciation & Amortization (CF) over 4 years is $13187.5, with a median of $13500.0 recorded in 2024.
  • The sharpest move saw Depreciation & Amortization (CF) surged 200.0% in 2023, then crashed 70.0% in 2025.
  • Over 4 years, Depreciation & Amortization (CF) stood at $24000.0 in 2022, then plummeted by 33.33% to $16000.0 in 2023, then tumbled by 43.75% to $9000.0 in 2024, then crashed by 44.44% to $5000.0 in 2025.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods came in at $5000.0, $3000.0, and $7000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.